Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

NDRA — ENDRA Life Sciences Inc. Dilution Risk Tracker

Track NDRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NDRA — Get alerts when the score changes →

As of August 28, 2026, ENDRA Life Sciences Inc. (NDRA) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. ENDRA Life Sciences Inc. has a market capitalization of $10.17M, 1.50M shares outstanding, 1 institutional holders tracked. Stored dilution-related fields include 31.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 3 months remaining
🔄 Reverse Split model est. 15%
• Only 3 months cash — financial pressure
🔔 Track NDRA — Get forecast alerts →

Market Data

Market Cap$10.17M
Shares Outstanding1.50M
Float1.20M
Cash$1.74M
DebtN/A
Short InterestN/A

Institutional Holdings

1 institutional holders · 12.8K shares
#1 Marex Group plc 12.8K shares

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest32.9K
Days to Cover1.7
% of Float2.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31
xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-01-23
Full SEC filing analysis available with free account

Recent News

No recent news

Factual NDRA Dilution Snapshot

ENDRA Life Sciences Inc. (NDRA) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track NDRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NDRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for NDRA
NDRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.